In a move that potentially violate all scientific principles, the World Health Organization (WHO) reached out to some pharmaceutical corporations to “accelerate” the creation and manufacture of a vaccine that would supposedly help fight Ebola.
According to the WHO, such a vaccine would be available by January 2015, which in scientific terms is a record. In normal conditions when science and not profit or urgency drive research and development of pharmaceutical products, it takes years or even decades to properly develop, test and approve a vaccine. However, the fear campaign initiated by health authorities and echoed by the media have propelled a call to fast-track the production of a new vaccine to fight Ebola.
As we have reported recently, the plan of the WHO and the pharmaceutical companies is to begin mass vaccinating people in Western Africa, where the first outbreak took place.
The Real Agenda News has learned that world health authorities intend to mandate the vaccination of whole countries as a way to end the current Ebola spread.
“It is conceivable that this epidemic will not end even if we pour all resources into it. You may only continue and may require a vaccine,” said Dr. Director of the National Institute of Allergy and Infectious Diseases of the United States.
“As the epidemic becomes more and more formidable, sometimes out of control, it is quite conceivable, if not likely, that we need to deploy the vaccine across the whole country to end the epidemic. This is clearly a possibility,” added Fauci.
With this, Dr. Fauci tells us two things: First, that vaccines that need to be tested for their efficacy and safety before being used in humans, may be used on people without following the proper process of clinical trials; and second, that governments will use force, if need be, to have citizens vaccinated.
The first vaccines against Ebola, will begin to be tested in the countries affected by the disease in West Africa, according to information provided by the World Health Organization (WHO). Traditionally, Africa has been the testing ground for many pharmaceutical products, especially vaccine.
Some people see the African continent as an open air laboratory that is always available to the large pharmaceutical corporations to test their newest products.
The WHO is now working “intensively” with pharmaceutical companies and regulators in order to speed up the application of a range of possible treatments for Ebola. This fact was confirmed by the Spanish Vaccinations Association.
The WHO has warned that, in any event, it will not be able to mass vaccinate people due to the limited amount of medication available. This has prompted some countries to demand more action in order to develop a vaccine faster, which is exactly what the medical mafia wants to hear. In most countries, pharmaceutical companies enjoy complete immunity against lawsuits that stem from health complications derived from vaccines.
The meeting of experts from the WHO on September 5 boosted the priority development of two vaccines: the chimpanzee adenovirus type 3 and the vesicular stomatitis.
None of them has yet been tested in humans to see if it is effective against Ebola, but the one known as ChAd3, itself has been used with other diseases and is apparently “safe”.
Studies to implement the use of a vaccine are already underway in the USA and they will also start in Europe and Africa, so the experts expect the first results on safety this coming November.
So far, the virus has no specific treatment or effective vaccine. Ebola has allegedly killed 3,338 people which has prompted scientists to consider it “the deadliest outbreak” in its history. Most people who supposedly were victims of Ebola lived in Guinea, Sierra Leone, Liberia and Nigeria and, in recent weeks, also in Spain and the United States.
Evidence of the hysteria that governs over scientific evidence was seen last August, when the WHO allowed the use of experimental treatments on the victims of Ebola.
The drug administered to humans is known as ZMapp, from Mapp Pharmaceuticals an American Company that is said to still be studying the effectiveness of the vaccine to later consider the challenge of high volume production.
This serum was applied successfully in the case of two Americans infected while visiting Liberia. However, the drug did not work in the case of a Spanish priest who was infected in the same country.
Another drug that is thought of as a possible option is TKM-Ebola, from the Canadian Tekmira Company. This drug received funding from the US Department of Defense. Its makers claim it has “successfully” completed the first phase of clinical trials.
The Public Health Agency of Canada, meanwhile, has developed an experimental vaccine, VSV-EBOV, which offers “promising” results in animals.
There are many more vaccines in development, as a variant of the rabies driven by the National Institutes of Health (NIH) and Thomas Jefferson University in the United States. This is perhaps the most concerning of all for the public. The National Institute of Health (NIH) and the Department of Health and Human Services (HHS) provided an exclusive license to Exxell BIO, Inc. in Minnesota to produce a Rabid Ebola vaccine against Ebola virus by using a modified form of rabies.
The director of the Jefferson Vaccine Center and professor of immunology and microbiology at the university, Matthias Schnell, recently claimed that the best way to end this epidemic is precisely the vaccine, although he also advocates for antibody-based therapies to treat patients who are already infected .
Another strong advocate of vaccination is the director of this department at WHO, Jean-Marie Okwo Bele, who has expressed his confidence that the implementation of “emergency procedures” will provide a definite product for next year.
His favorite project is that of the British company GlaxoSmithKline, as he says that animal testing have obtained “excellent results”.
Luis R. Miranda is the Founder and Editor of The Real Agenda. His 16 years of experience in Journalism include television, radio, print and Internet news. Luis obtained his Journalism degree from Universidad Latina de Costa Rica, where he graduated in Mass Media Communication in 1998. He also holds a Bachelor’s Degree in Broadcasting from Montclair State University in New Jersey. Among his most distinguished interviews are: Costa Rican President Jose Maria Figueres and James Hansen from NASA Space Goddard Institute. Read more about Luis.